Literature DB >> 2185329

Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis.

P Fisch1, M Malkovsky, E Braakman, E Sturm, R L Bolhuis, A Prieve, J A Sosman, V A Lam, P M Sondel.   

Abstract

Non-MHC-restricted killer cells are cytotoxic lymphocytes that can mediate cytolysis of most tumor targets without apparent selectivity and restriction by the MHC, particularly when activated with IL-2. These effector cells include predominantly NK cells and T cells expressing the TCR-gamma/delta. We found that TCR-gamma/delta-1+, delta TSC1-, BB3+, Ti gamma A+ T cell clones mediate a characteristic cytolytic pattern of non-MHC-restricted cytolysis that is markedly different from NK clones and alpha/beta T cell clones derived from the peripheral blood of the same normal individuals. The characteristic finding is that all BB3/Ti gamma A+ gamma/delta clones mediate strong cytolysis of Daudi cells but they do not lyse Raji cells. In contrast, NK clones from the same donors mediate strong cytolysis of both Daudi and Raji targets. Cytotoxicity by the gamma/delta clones on certain target cells such as Daudi and Molt 4 can be specifically inhibited by mAbs reactive against the TCR-gamma/delta. Therefore, the TCR-gamma/delta on these clones either directly recognizes target epitopes on some tumor targets or it is involved in the regulation of their cytotoxic function. The expression of TCR-gamma/delta products reacting with the BB3 and Ti gamma A mAbs reflects the usage of identical TCR-gamma/delta V region genes that appear to be associated with the characteristic pattern of non-MHC-restricted cytotoxicity displayed by this major subset of human peripheral blood gamma/delta cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185329      PMCID: PMC2187884          DOI: 10.1084/jem.171.5.1567

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones.

Authors:  S Shaw; G E Luce; R Quinones; R E Gress; T A Springer; M E Sanders
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

2.  Two forms of the T-cell receptor gamma protein found on peripheral blood cytotoxic T lymphocytes.

Authors:  M B Brenner; J McLean; H Scheft; J Riberdy; S L Ang; J G Seidman; P Devlin; M S Krangel
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

3.  Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.

Authors:  R J van de Griend; R L Bolhuis; G Stoter; R C Roozemond
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

Review 4.  The T cell receptor.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

5.  Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.

Authors:  R J van de Griend; W J Tax; B A van Krimpen; R J Vreugdenhil; C P Ronteltap; R L Bolhuis
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

6.  Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody.

Authors:  J Borst; J J van Dongen; R L Bolhuis; P J Peters; D A Hafler; E de Vries; R J van de Griend
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

7.  Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture.

Authors:  E Ciccone; O Viale; C Bottino; D Pende; N Migone; G Casorati; G Tambussi; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

8.  A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).

Authors:  E Ciccone; S Ferrini; C Bottino; O Viale; I Prigione; G Pantaleo; G Tambussi; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

9.  A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes.

Authors:  F Triebel; F Faure; M Graziani; S Jitsukawa; M P Lefranc; T Hercend
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

10.  Evidence that the T cell antigen receptor may not be involved in cytotoxicity mediated by gamma/delta and alpha/beta thymic cell lines.

Authors:  J H Phillips; A Weiss; B T Gemlo; A A Rayner; L L Lanier
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  52 in total

Review 1.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections.

Authors:  M Wallace; A M Scharko; C D Pauza; P Fisch; K Imaoka; S Kawabata; K Fujihashi; H Kiyono; Y Tanaka; B R Bloom; M Malkovsky
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

3.  Preferential activation of peripheral blood V gamma 9+ gamma/delta T cells by group A, B and C but not group D or F streptococci.

Authors:  A Bender; D Kabelitz
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

4.  Dual antigenic recognition by cloned human gamma delta T cells.

Authors:  J Holoshitz; L M Vila; B J Keroack; D R McKinley; N K Bayne
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

5.  Increase of lymphocytes bearing the gamma/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis.

Authors:  E Savilahti; T Reunala; M Mäki
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

6.  Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.

Authors:  Andrew M Hebbeler; Cristiana Cairo; Jean Saville Cummings; C David Pauza
Journal:  Cancer Immunol Immunother       Date:  2006-11-28       Impact factor: 6.968

7.  Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

Authors:  Marie Tosolini; Frédéric Pont; Mary Poupot; François Vergez; Marie-Laure Nicolau-Travers; David Vermijlen; Jean-Emmanuel Sarry; Francesco Dieli; Jean-Jacques Fournié
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

8.  BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.

Authors:  Mahboob Salim; Timothy J Knowles; Alfie T Baker; Martin S Davey; Mark Jeeves; Pooja Sridhar; John Wilkie; Carrie R Willcox; Hachemi Kadri; Taher E Taher; Pierre Vantourout; Adrian Hayday; Youcef Mehellou; Fiyaz Mohammed; Benjamin E Willcox
Journal:  ACS Chem Biol       Date:  2017-09-14       Impact factor: 5.100

9.  Proliferative and cytolytic responses of human gamma delta T cells display a distinct specificity pattern.

Authors:  G Haecker; H Wagner
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

Review 10.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.